228 related articles for article (PubMed ID: 32090124)
1. Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study.
Mosavat M; Omar SZ; Jamalpour S; Tan PC
J Diabetes Res; 2020; 2020():9072492. PubMed ID: 32090124
[TBL] [Abstract][Full Text] [Related]
2. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
[TBL] [Abstract][Full Text] [Related]
3. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
Bonde L; Vilsbøll T; Nielsen T; Bagger JI; Svare JA; Holst JJ; Larsen S; Knop FK
Diabetes Obes Metab; 2013 Aug; 15(8):713-20. PubMed ID: 23406269
[TBL] [Abstract][Full Text] [Related]
4. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
5. Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.
Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2012 May; 55(5):1338-45. PubMed ID: 22349073
[TBL] [Abstract][Full Text] [Related]
6. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
7. Incretin Hypersecretion in Gestational Diabetes Mellitus.
Fritsche L; Heni M; Eckstein SS; Hummel J; Schürmann A; Häring HU; Preißl H; Birkenfeld AL; Peter A; Fritsche A; Wagner R
J Clin Endocrinol Metab; 2022 May; 107(6):e2425-e2430. PubMed ID: 35180296
[TBL] [Abstract][Full Text] [Related]
8. Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy.
Kelstrup L; Clausen TD; Mathiesen ER; Hansen T; Holst JJ; Damm P
J Clin Endocrinol Metab; 2015 May; 100(5):1967-75. PubMed ID: 25781355
[TBL] [Abstract][Full Text] [Related]
9. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
10. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
Green BD; Gault VA; O'Harte FP; Flatt PR
Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
[TBL] [Abstract][Full Text] [Related]
12. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
13. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
14. The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.
Fisman EZ; Tenenbaum A
Cardiovasc Diabetol; 2021 Nov; 20(1):225. PubMed ID: 34819089
[TBL] [Abstract][Full Text] [Related]
15. Incretins, Pregnancy, and Gestational Diabetes.
Nikolic D; Al-Rasadi K; Al Busaidi N; Al-Waili K; Banerjee Y; Al-Hashmi K; Montalto G; Rizvi AA; Rizzo M; Al-Dughaishi T
Curr Pharm Biotechnol; 2016; 17(7):597-602. PubMed ID: 26813306
[TBL] [Abstract][Full Text] [Related]
16. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
Pathak V; Vasu S; Flatt PR; Irwin N
Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
[TBL] [Abstract][Full Text] [Related]
18. Incretin secretion in humans is under the influence of cannabinoid receptors.
Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
[TBL] [Abstract][Full Text] [Related]
19. Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance.
Stinson SE; Fernández de Retana Alzola I; Brünner Hovendal ED; Lund MAV; Fonvig CE; Holm LA; Jonsson AE; Frithioff-Bøjsøe C; Christiansen M; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Hartmann B; Holm JC; Hansen T
J Clin Endocrinol Metab; 2024 May; 109(6):1590-1600. PubMed ID: 38087928
[TBL] [Abstract][Full Text] [Related]
20. Serum Levels of Incretin Hormones - GLP-1 and GIP in Patients with Type 1 Diabetes Mellitus.
Stanchev PE; Orbetzova MM; Terzieva DD; Davcheva D; Iliev DA; Petrov SV; Koleva DI; Nonchev BI
Folia Med (Plovdiv); 2019 Mar; 61(1):76-83. PubMed ID: 31237842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]